Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 30 Records) |
| Query Trace: Neoplasms and TOP2A[original query] |
|---|
| Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization. Archives of pathology & laboratory medicine 2005 1 129 (1): 39-46. Murthy Sabita K, Magliocco Anthony M, Demetrick Douglas |
| Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Aug 27 (24): 3881-6. Tubbs Raymond, Barlow William E, Budd G Thomas, Swain Eric, Porter Peggy, Gown Allen, Yeh I-Ten, Sledge George, Shapiro Charles, Ingle James, Haskell Charles, Albain Kathy S, Livingston Robert, Hayes Daniel |
| Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. Journal of the National Cancer Institute 2009 May 101 (9): 644-50. O'Malley F P, Chia S, Tu D, Shepherd L E, Levine M N, Bramwell V H, Andrulis I L, Pritchard K |
| Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer. Breast cancer research and treatment 2010 Apr 120 (2): 481-9. Konecny Gottfried E, Pauletti Giovanni, Untch Michael, Wang He-Jing, Möbus Volker, Kuhn Walther, Thomssen Christoph, Harbeck Nadia, Wang Ling, Apple Sophia, Jänicke Fritz, Slamon Dennis |
| Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab. Journal of translational medicine 2012 10 (1): 212. Fountzilas George, Christodoulou Christos, Bobos Mattheos, Kotoula Vassiliki, Eleftheraki Anastasia G, Xanthakis Ioannis, Batistatou Anna, Pentheroudakis George, Xiros Nikolaos, Papaspirou Irene, Koumarianou Anna, Papakostas Pavlos, Bafaloukos Dimitrios, Skarlos Dimosthenis V, Kalogeras Konstantine |
| Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials. BMC cancer 2013 13 (1): 163. Fountzilas George, Dafni Urania, Bobos Mattheos, Kotoula Vassiliki, Batistatou Anna, Xanthakis Ioannis, Papadimitriou Christos, Kostopoulos Ioannis, Koletsa Triantafillia, Tsolaki Eleftheria, Televantou Despina, Timotheadou Eleni, Koutras Angelos, Klouvas George, Samantas Epaminontas, Pisanidis Nikolaos, Karanikiotis Charisios, Sfakianaki Ioanna, Pavlidis Nicholas, Gogas Helen, Linardou Helena, Kalogeras Konstantine T, Pectasides Dimitrios, Dimopoulos Meletios |
| Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer. Medical oncology (Northwood, London, England) 2013 Jun 30 (2): 545. Moiseyenko Vladimir M, Volkov Nikita M, Suspistin Evgeny N, Yanus Grigoriy A, Iyevleva Aglaya G, Kuligina Ekatherina Sh, Togo Alexandr V, Kornilov Alexandr V, Ivantsov Alexandr O, Imyanitov Evgeny |
| Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population. Gene 2014 Feb 535 (2): 225-32. Qiu Yue, Zhang Zuo-Yang, Du Wei-Dong, Ye Lei, Xu Song, Zuo Xian-Bo, Zhou Fu-Sheng, Chen Gang, Ma Xue-Ling, Schneider Marion E, Xia Hong-Zhen, Zhou Yuan, Wu Ji-Feng, Yuan-Hong Xu, Zhang Xue-J |
| Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer. International journal of molecular sciences 2014 15 (7): 12458-68. Salvi Samanta, Calistri Daniele, Gurioli Giorgia, Carretta Elisa, Serra Luigi, Gunelli Roberta, Zoli Wainer, Casadio Valenti |
| HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics. Breast cancer research and treatment 2014 May 145 (1): 193-203. Fasching Peter A, Weihbrecht Sebastian, Haeberle Lothar, Gasparyan Armen, Villalobos Ivonne E, Ma Yanling, Ekici Arif B, Wachter David L, Hartmann Arndt, Beckmann Matthias W, Slamon Dennis J, Press Michael |
| Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification. Cellular oncology (Dordrecht) 2014 Apr 37 (2): 107-18. Tabarestani Sanaz, Ghaderian Sayyed Mohammad Hossein, Rezvani Hamid, Mirfakhraie Reza, Ebrahimi Abdolali, Attarian Hamid, Rafat Jahangir, Ghadyani Mojtaba, Alavi Hossein Afshin, Kamalian Naser, Rakhsha Afshin, Azargashb Eznoll |
| [Endometrial cancer in young women--clinical and molecular aspects]. Ginekologia polska 2014 12 85 (10): 754-9. Lapi?ska-Szumczyk Sylwia, Supernat Anna, ?aczek Anna J, Majewska Hanna, Gulczy?ski Jacek, Sawicki Sambor, Biernat Wojciech, Wydra Dariu |
| TOP2A gene copy number change in breast cancer. Journal of clinical pathology 2014 May 67 (5): 420-5. Engstrøm M J, Ytterhus B, Vatten L J, Opdahl S, Bofin A |
| Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Jul 26 (7): 1363-71. Beltrame L, Di Marino M, Fruscio R, Calura E, Chapman B, Clivio L, Sina F, Mele C, Iatropoulos P, Grassi T, Fotia V, Romualdi C, Martini P, Noris M, Paracchini L, Craparotta I, Petrillo M, Milani R, Perego P, Ravaggi A, Zambelli A, Ronchetti E, D'Incalci M, Marchini |
| Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers. Molecular oncology 2015 Jun 9 (6): 1207-17. Sønderstrup Ida Marie Heeholm, Nygård Sune Boris, Poulsen Tim Svenstrup, Linnemann Dorte, Stenvang Jan, Nielsen Hans Jørgen, Bartek Jiri, Brünner Nils, Nørgaard Peter, Riis Le |
| Dual Specificity Phosphatase 6 (DUSP6) Polymorphism Predicts Prognosis of Inoperable Non-Small Cell Lung Cancer after Chemoradiotherapy. Clinical laboratory 2016 62 (3): 301-10. Wang Tian-Lu, Song Ying-Qiu, Ren Yang-Wu, Zhou Bao-Sen, Wang He-Tong, Bai Lu, Zhang Hai-Bo, Yu Hong, Zhao Yu-X |
| Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer. Oncology reports 2017 May 37 (5): 3026-3036. Dimas-González Jisela, Maldonado-Lagunas Vilma, Díaz-Chávez José, López-Arellano María Eugenia, Muñoz-Camacho José, Terán-Porcayo Marco Antonio, Lagunas-Martínez Alfre |
| Association of Topoisomerase II (TOP2A) and Dual-Specificity Phosphatase 6 (DUSP6) Single Nucleotide Polymorphisms with Radiation Treatment Response and Prognosis of Lung Cancer in Han Chinese. Medical science monitor : international medical journal of experimental and clinical research 2017 Feb 23 984-993. Wang Tian-Lu, Ren Yang-Wu, Wang He-Tong, Yu Hong, Zhao Yu-X |
| Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer. BMC gastroenterology 2017 1 17 (1): 2. Cao Yongkuan, Zhang Guohu, Wang Peihong, Zhou Jun, Gan Wei, Song Yaning, Huang Ling, Zhang Ya, Luo Guode, Gong Jiaqing, Zhang L |
| Racial Disparities in the Molecular Landscape of Cancer. Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
| Dual-specificity phosphatase 6 genetic variants associated with risk of lung squamous cell carcinoma in Han Chinese. Journal of cancer research and therapeutics 2018 14 (Supplement): S72-S78. Wang Tian-Lu, Song Ying-Qiu, Ren Yang-Wu, Zhou Bao-Sen, Wang He-Tong, Gao Ya, Yu Hong, Zhao Yu-X |
| Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patients. International journal of cancer 2019 9 146 (11): 3087-3097. Nikanjam Mina, Arguello David, Gatalica Zoran, Swensen Jeff, Barkauskas Donald A, Kurzrock Razel |
| Identification of potential core genes and miRNAs in testicular seminoma via bioinformatics analysis. Molecular medicine reports 2019 9 20 (5): 4013-4022. Wang Kai, Chen Yun, Zhao Zhihong, Feng Meiying, Zhang Shouqu |
| Clinical analysis of 21-gene recurrence score test in hormone receptor-positive early-stage breast cancer. Oncology letters 2019 Jun 17 (6): 5469-5480. Zhu Lizhe, Ma Nan, Wang Bin, Zhou Can, Yan Yu, Wang Ke, He Jianjun, Ren |
| Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 4 25 (13): 3986-3995. Loibl Sibylle, Treue Denise, Budczies Jan, Weber Karsten, Stenzinger Albrecht, Schmitt Wolfgang D, Weichert Wilko, Jank Paul, Furlanetto Jenny, Klauschen Frederick, Karn Thomas, Pfarr Nicole, von Minckwitz Gunter, Möbs Markus, Jackisch Christian, Sers Christine, Schneeweiss Andreas, Fasching Peter A, Schem Christian, Hummel Michael, van Mackelenbergh Marion, Nekljudova Valentina, Untch Michael, Denkert Carst |
| Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients. Cancer medicine 2019 Dec . Grenda Anna, B?ach Justyna, Szczyrek Micha?, Krawczyk Pawe?, Nico? Marcin, Ku?nar Kami?ska Barbara, Jakimiec Monika, Balicka Gra?yna, Chmielewska Izabela, Batura-Gabryel Halina, Sawicki Marek, Milanowski Janu |
| A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence. Clinical & experimental metastasis 2019 12 37 (2): 257-267. He Jingni, Tian Zhong, Yao Xu, Yao Baiyu, Liu Yuan, Yang Jiape |
| Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma. Frontiers in oncology 2020 10 607130. Qian Jie, Chen Rongrong, Zhao Ruiying, Han Yuchen, Yu Yongfe |
| Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease. Cancer medicine 2020 1 9 (4): 1441-1450. Gatalica Zoran, Vranic Semir, Krušlin Božo, Poorman Kelsey, Stafford Phillip, Kacerovska Denisa, Senarathne Wijendra, Florento Elena, Contreras Elma, Leary Alexandra, Choi April, In Gino |
| Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients. Archives of medical science : AMS 2021 3 17 (2): 474-480. Nico? Marcin, Rolska-Kopi?ska Anna, Krawczyk Pawe?, Grenda Anna, Bo?yk Aleksandra, Szczyrek Micha?, Milanowski Janu |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: